Cinven makes second pharma play with new fund
The London-headquartered firm has funded the acquisition of Amdipharm with capital from its fifth fund, which has now reached €4bn as it pursues a €5bn target.
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .Issues with signing in? Click here
Don't have an account? Register now
The London-headquartered firm has funded the acquisition of Amdipharm with capital from its fifth fund, which has now reached €4bn as it pursues a €5bn target.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group.Copyright PEI Media
Not for publication, email or dissemination